The ZETA
Digital Assistant
  • Last
    search queries
  • Last
    webinars
  • Last
    blog posts

Your ZETA Digital Assistant

Welcome back!

Recently viewed

No results

You have no results yet.

Maybe also interesting

No results

You have no results yet.

Press Release: ZETA & BIOTREE: Biotech cooperation for comprehensive engineering and automation solutions

11. August 2022 by Peter Hartmann About, Automation, Biotech, Cooperations, Process Technology, ZETA News

The biopharmaceutical market in the Asian region shows enormous growth potential. The internationally active ZETA Group has established itself as an end-to-end solution provider for the pharmaceutical and biotech industries in this dynamic environment. With its majority interest in the Indian engineering and plant construction specialist Biotree, ZETA has intensified its development of the Asian market. Local companies benefit from the high quality of their service and performance portfolio.

The Asian biopharmaceutical market is growing rapidly. With an annual growth rate of 13%, India, is considered an extremely dynamic environment for companies in this industry.

The international ZETA Group is also taking advantage of this momentum with its majority stake in Biotree, the Indian engineering and plant construction “Together, we will intensify our market development in the Asian region and further expand services for our customers, particularly in India and Southeast Asia," says Andreas Marchler, CEO of the ZETA Group who is well prepared for the future.

Andreas Marchler - Managing Director

Together, we will intensify our market development in the Asian region and further expand services for our customers, particularly in India and Southeast Asia

Contact: Andreas Marchler

Managing Director

Common engineering and supply network

Biotree will be integrated into ZETA's global engineering and delivery network and complete the service portfolio in the Asian region.

We are pooling our resources and skills: global presence with engineering, plant construction, and automation hubs in Europe, the USA, and Asia. This is paired with in-depth knowledge of local market requirements," emphasizes Dr. Anil Paul Kariath, CEO of Biotree, highlighting the benefits of the partnership.

"It is very important for us to offer our customers in all parts of the world the same expertise and high quality in the fields of engineering, plant construction, automation, and digitalization. With Biotree, we now have an Asian partner on board that fulfills all of these requirements excellently. ZETA is thus consistently implementing the strategy of offering high-quality end-to-end solutions for the pharmaceutical and biotech industry globally, from engineering, construction, automation, digitization to qualification," adds Andreas Marchler in conclusion.

ZETA is an end-to-end solution provider for the pharmaceutical and biotech industries.
Biotree is integrated into ZETA's global engineering and delivery network and completes its service portfolio in the Asian region.
Biotree and ZETA - A promising combination
"We are pooling our resources and skills: global presence with engineering, plant construction, and automation hubs in Europe, the USA, and Asia. This is paired with in-depth knowledge of local market requirements", says Dr. Anil Paul Kariath, Managing Director BPE Biotree India PVT. LTD
Contact: Andreas Pompenig
Public Relations

Our Expert IS LOOKING FORWARD TO HEARING FROM YOU!

Related Posts

Event: ACHEMA 2022

Major project: blood plasma production at Octapharma more than doubled - thanks to ZETA

Press release: ZETA & SIGMA: Concentrated automation expertise for the pharmaceutical and biotech industry

Movie: EPCM Project for life-saving drugs

Press Release: Eridia - 50/50 Joint Venture of ZETA and Bühler

Video: ZETA Germany is growing – an interview with Gerald Dollberger

Close

ZETA Blog

Erhalten Sie interessante Themen aus dem Blog als Newsletter!